Scientists at Israel’s Bar-Ilan University and Hadassah-University Medical Center, have developed a treatment for multiple myeloma. The patient’s T-cells are combined with a chimeric antigen receptor (CAR) molecule. In Phase 1 human trials at Hadassah.
Reprogramming the immune system to fight cancer
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.